Global Cancer Movement: Women in Oncology

In the inaugural event of the Global Cancer Movement, initiated by OncoDaily, Dr. Verna Vanderpuye, a renowned clinical oncologist at Korlebu Teaching Hospital, explores the groundbreaking insights from the Lancet Commission on Women, Power, and Cancer, which she co-chaired. The virtual event, held from December 6-8, 2024, brought together global experts to discuss how systemic changes in cancer care can help reduce premature cancer-related deaths and promote gender equity in oncology.

Verna Vanderpuye discusses the critical issue of gender disparities in oncology, drawing insights from the Lancet Commission on Women, Power, and Cancer, which they co-chaired. The commission’s findings highlight the significant number of premature cancer-related deaths among women, emphasizing that 1.5 million out of 2.3 million annual deaths could be prevented through primary prevention, early detection, and better access to optimal care.

The study focused on estimating the economic impact of cancer on women, families, and society, while also addressing the underrepresentation of women in oncology leadership. Key recommendations from the commission include the development and enforcement of laws to reduce risk exposure, gender-transformative strategies for improved access to care, and policies ensuring equitable opportunities for women in research and leadership.

Verna Vanderpuye delves into the longstanding male dominance in medicine, attributing it to deeply ingrained cultural beliefs and structural biases. They highlight the importance of female role models in leadership positions, which can have a cascading effect by encouraging more women to enter and progress in the field. However, women in medicine face unique challenges, such as sexual harassment, unconscious bias, and work-life balance struggles, leading many to temporarily or permanently leave their academic or professional careers.

Analyzing gender representation in oncology leadership, the speaker presents data from 424 organizations worldwide, showing stark disparities. In Africa, Europe, and Asia, for every two men in leadership roles, there is only one woman, whereas North America, South America, and Oceania have achieved gender parity.

Women are particularly underrepresented in research institutions, hospital treatment centers, and government organizations, with better representation mainly in patient support and advocacy groups. Despite making up 70% of the global healthcare workforce, women hold only 25% of leadership positions.

The discussion moves to barriers in career advancement, citing findings from an ESMO survey that compared data from 2016 and 2021. Common challenges include a lack of leadership development opportunities, societal pressures, and unconscious bias, with work-life balance being a significant issue for both genders. Institutional barriers, particularly in Africa, include insufficient resources, inflexible maternity leave policies, and financial constraints that disproportionately affect women.

Further challenges are highlighted, including the undervaluation of women in oncology, underrepresentation in research authorship, and significant pay gaps driven by biases in insurance reimbursement for different cancer types. Women in oncology often face discrimination, struggle with professional recognition, and experience a lack of mentorship. Verna underscores the need for comprehensive policies to support female oncologists in balancing career and family life.

Lastly Verna touches on the emotional and professional burdens carried by female oncologists, such as higher rates of burnout, delayed childbearing, and career limitations due to gender bias. They emphasize the need for structural changes, better support systems, and stronger advocacy to address these persistent disparities and promote gender equity in oncology leadership and professional growth.